Company Analysis The Joint Corp.
1. Summary
Advantages
- The stock's return over the last year (29.27%) is higher than the sector average (-35.85%).
Disadvantages
- Price (12.47 $) is higher than fair price (9.48 $)
- Dividends (0%) are below the sector average (0.5442%).
- Current debt level 6.63% has increased over 5 years from 4.68%.
- The company's current efficiency (ROE=-39.41%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
The Joint Corp. | Healthcare | Index | |
---|---|---|---|
7 days | 0.4% | -25.7% | -0.3% |
90 days | -25.8% | -39.4% | 8.1% |
1 year | 29.3% | -35.8% | 30.1% |
JYNT vs Sector: The Joint Corp. has outperformed the "Healthcare" sector by 65.12% over the past year.
JYNT vs Market: The Joint Corp. has underperformed the market marginally by -0.8543% over the past year.
Stable price: JYNT is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: JYNT with weekly volatility of 0.5629% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (12.47 $) is higher than the fair price (9.48 $).
Price is higher than fair: The current price (12.47 $) is 24% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (190.71) is higher than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (190.71) is higher than that of the market as a whole (48.79).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.5) is higher than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (5.5) is higher than that of the market as a whole (3.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.16) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (1.16) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.62) is higher than that of the sector as a whole (-22.15).
EV/Ebitda vs Market: The company's EV/Ebitda (14.62) is lower than that of the market as a whole (28.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -79.1% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-79.1%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).
5.4. ROE
ROE vs Sector: The company's ROE (-39.41%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (-39.41%) is lower than that of the market as a whole (10.82%).
5.5. ROA
ROA vs Sector: The company's ROA (-11.19%) is lower than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (-11.19%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5442%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (32.64%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription